@article{TCR8066,
author = {Giandomenico Roviello and Giulia Borsella and Daniele Generali},
title = {Expanding treatment options for metastatic gastric cancer},
journal = {Translational Cancer Research},
volume = {5},
number = {Suppl 1},
year = {2016},
keywords = {},
abstract = {Li et al. published a clinical study evaluating the efficacy and safety of Apatinib (a small-molecule tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 (VEGFR-2) versus placebo in the treatment of patients with gastric or gastroesophageal junction adenocarcinoma for whom at least two lines of prior chemotherapy had failed (1).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/8066}
}